OsteoCentric Technologies Secures $30 Million in Growth Capital

OsteoCentric Technologies secured $30 million led by Squadron Capital and OnPoint Advisors. The growth capital will fuel OsteoCentric Trauma's new product introductions which address implant instability and expand applications of UnifiMI™ across spine, joint reconstruction, sports, extremities, veterinary, limb salvage and dental implants.

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us